Yoon G, Kam MK, Koh YH, Jo C
A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)
Deshalb ist das Risiko einer L-Carnitin-Unterversorgung bei fleischarmer Ernhrung erhht
Muscle Quality Enhancement Muscle tissue undergoes qualitative improvements that exceed simple hypertrophy
The active effects may be short, but detection windows can vary depending on dosage, frequency of use, metabolism, and testing methods
Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS)